Download MendeleyStructure, Mechanism, and Inhibition ofAspergillus fumigatusThioredoxin Reductase.
Marshall, A.C., Kidd, S.E., Lamont-Friedrich, S.J., Arentz, G., Hoffmann, P., Coad, B.R., Bruning, J.B.(2019) Antimicrob Agents Chemother 63
- PubMed: 30642940
- DOI: https://doi.org/10.1128/AAC.02281-18
- Primary Citation of Related Structures:
6BPY - PubMed Abstract:
Aspergillus fumigatus infections are associated with high mortality rates and high treatment costs. Limited available antifungals and increasing antifungal resistance highlight an urgent need for new antifungals. Thioredoxin reductase (TrxR) is essential for maintaining redox homeostasis and presents as a promising target for novel antifungals. We show that ebselen [2-phenyl-1,2-benzoselenazol-3(2H)-one] is an inhibitor of A. fumigatus TrxR ( K i = 0.22 μM) and inhibits growth of Aspergillus spp., with in vitro MIC values of 16 to 64 µg/ml. Mass spectrometry analysis demonstrates that ebselen interacts covalently with a catalytic cysteine of TrxR, Cys148. We also present the X-ray crystal structure of A. fumigatus TrxR and use in silico modeling of the enzyme-inhibitor complex to outline key molecular interactions. This provides a scaffold for future design of potent and selective antifungal drugs that target TrxR, improving the potency of ebselen toward inhbition of A. fumigatus growth.
Organizational Affiliation:
Institute for Photonics and Advanced Sensing, School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.
